Structural Basis for HTLV-1 Protease Inhibition by the HIV-1 Protease Inhibitor Indinavir

Structural Basis for HTLV-1 Protease Inhibition by the HIV-1 Protease Inhibitor Indinavir Crystal-Structure-Based Design and Synthesis of Novel C-Terminal Inhibitors of HIV Protease Structure-Based Design of Novel HIV-1 Protease Inhibitors To Combat Drug Resistance Effectiveness of Nonpeptide Clinical Inhibitor TMC-114 on HIV-1 Protease with Highly Drug Resistant Mutations D30N, I50V, and L90M N1-Heterocyclic pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase Design, Synthesis, Protein−Ligand X-ray Structure, and Biological Evaluation of a Series of Novel Macrocyclic Human Immunodeficiency Virus-1 Protease Inhibitors to Combat Drug Resistance An Orally Bioavailable Pyrrolinone Inhibitor of HIV-1 Protease:  Computational Analysis and X-ray Crystal Structure of the Enzyme Complex A Combinatorial Library of Indinavir Analogues and Its In Vitro and In Vivo Studies Rational Design of Potent Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase 5-Chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase